Topics and Expertise: pharmacogenomics

Giacomini to receive Therapeutic Frontiers Lecture Award

Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, will receive the 2010 Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy on October 17, 2010, in Austin, Texas at

Giacomini to lead $15.1 million in research funding to improve the use of drugs in individuals

Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences and an expert in the field of pharmacogenomics, is leading two research projects funded by two grants totaling $15.1 million over the next five years to expand research into how ge

Symposium on the future of therapeutics inaugurates new UCSF department

In the first symposium held by the newly minted UCSF Department of Bioengineering and Therapeutic Sciences, researchers described progress in the fields of systems biology, pharmacogenomics, and bioengineering, and how scientists in these fields are working in concert to develop novel diagnostics an

Kroetz discusses pharmacogenomics on KQED Quest radio

UCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009.

Scientists explain how they are making therapeutics “intelligent”

UCSF scientists describe how their research is aiming to make therapeutics sophisticated, highly effective, and tailored to the different needs of individuals.

Giacomini and Peck honored with ASCPT awards

Kathy Giacomini, PhD, and Carl Peck, MD, faculty members in the UCSF Department of Bioengineering and Therapeutic Sciences (BTS), received awards from the American Society for Clinical Pharmacology and Therapeutics (ASCPT) at the society's annual meeting held in National Harbor, Maryland, USA,...

Pharmacogenomics research spans school agenda

Pharmacogenomics research at the UCSF School of Pharmacy extends from a better understanding of information derived from the Human Genome Project to research on specific genetic differences in humans and how they might affect an individual's response to a medication.

Kroetz uses pharmacogenetics to determine the best treatment options for leukemia patients

Some leukemia cells supercharge cell pumps to get rid of chemotherapy. UCSF School of Pharmacy faculty member and pharmacogenetics researcher Deanna Kroetz, PhD, is aiming toward a simple way to identify these tumors, select the best treatment and avoid complications.

Giacomini receives Dawson Award

Kathy M.

Giacomini and Benet honored by international peers

Kathy M. Giacomini, PhD, chair, department of biopharmaceutical sciences and Leslie Z. Benet, PhD, professor in the same department, were both honored at the Pharmaceutical Sciences World Congress, held May 29 to June 4, 2004 in Kyoto, Japan.

Pages